Table 2. Clinical and demographic features of RLS (+) patients and RLS (-) patients in the urticaria group.
| Characteristics | RLS (+) n (%) |
RLS (-) n (%) |
P value | |
|---|---|---|---|---|
| Age (Mean ± SD) | 45.36 ± 15.12 | 36.46 ± 13.22 | 0.032 | |
| Limits | 21-70 | 18-70 | ||
| Gender | Male | 5 (17.8%) | 40 (35.7%) | 0.463 |
| Female | 23 (82.2%) | 72 (64.3%) | ||
| Obese | 7 (25.0%) | 12 (10.7%) | 0.493 | |
| Atopy | 5 (17.8%) | 21(18.7%) | 0.948 | |
| Use of antihistaminic drugs (+) | 16 (57.1%) | 48 (42.8%) | 0.422 | |
| Family history of urticaria (+) | 8 (28.5%) | 28 (25.0%) | 0.898 | |
| Poor sleep quality (+) | 21 (75.0%) | 69 (61.6%) | 0.697 | |
| UAS (Mean ± SD) | 3.24 ± 1.52 | 2.83 ± 1.32 | 0.432 | |
| limits | 1-6 | 1-6 | ||
| VAS (Mean ± SD) | 7.95 ± 2.75 | 6.77 ± 3.08 | 0.135 | |
| limits | 1-10 | 0-10 | ||
| Disease duration, months (Mean ± SD) | 82.75 ± 28.13 | 62.54 ± 10.84 | 0.524 | |
| limits | 2-480 | 2-360 | ||
| BMI (Mean ± SD) | 27.32 ± 1.23 | 25.84 ± 0.72 | 0.998 | |
| Limits | 19.05-40.83 | 17.01-36.57 | ||
RLS, restless legs syndrome; UAS, urticaria activity score; VAS, visual analog scale for severity of itch; BMI, body mass index.